GH Research PLC
GHRS- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001855129
No open-market purchases or sales by GH Research PLC insiders were filed in the last 90 days; 63 institutions reported holding it in 13F filings for Q2 2026, worth $1.38B in total; no superinvestor holds it.
Q1 2023 vs. Q4 2022
How the institutions holding GH Research PLC changed between Q4 2022 and Q1 2023.
All holders in Q1 2023All holders in Q4 2022
| Measure | Q4 2022 | Q1 2023 | Change |
|---|---|---|---|
| Holders | 32 | 29 | −3 |
| Shares | 30.9M | 29.7M | −1.20M (−3.9%) |
| Value | $299.5M | $237.2M | −$62.2M (−20.8%) |
New holders (2)
Institutions that held GH Research PLC at the end of Q1 2023 but not at the end of Q4 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Renaissance Technologies LLC | 10,800 | $86.0K | 0.00% |
| Farther Finance Advisors, LLC | 100 | $799 | 0.00% |
Sold out (5)
Institutions that held GH Research PLC at the end of Q4 2022 and filed for Q1 2023 without it.
| Institution | Shares, Q4 2022 | Value, Q4 2022 |
|---|---|---|
| HighVista Strategies LLC | 65,597 | $637.6K |
| Point72 Asset Management, L.P. | 24,600 | $239.1K |
| Cornerstone Investment Partners, LLC | 14,800 | $143.9K |
| Exchange Traded Concepts, LLC | 11,510 | $111.3K |
| Cubist Systematic Strategies, LLC | 700 | $6.80K |